JP2008526975A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526975A5
JP2008526975A5 JP2007551363A JP2007551363A JP2008526975A5 JP 2008526975 A5 JP2008526975 A5 JP 2008526975A5 JP 2007551363 A JP2007551363 A JP 2007551363A JP 2007551363 A JP2007551363 A JP 2007551363A JP 2008526975 A5 JP2008526975 A5 JP 2008526975A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
formula
compound
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007551363A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526975A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/001020 external-priority patent/WO2006076455A2/en
Publication of JP2008526975A publication Critical patent/JP2008526975A/ja
Publication of JP2008526975A5 publication Critical patent/JP2008526975A5/ja
Withdrawn legal-status Critical Current

Links

JP2007551363A 2005-01-13 2006-01-12 ピラゾロ[3,4−d]ピリミジンエーテルを調製するための方法 Withdrawn JP2008526975A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64371205P 2005-01-13 2005-01-13
PCT/US2006/001020 WO2006076455A2 (en) 2005-01-13 2006-01-12 Processes for preparing pyrazolo[3,4-d]pyrimidine ethers

Publications (2)

Publication Number Publication Date
JP2008526975A JP2008526975A (ja) 2008-07-24
JP2008526975A5 true JP2008526975A5 (enExample) 2009-02-19

Family

ID=36463499

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007551363A Withdrawn JP2008526975A (ja) 2005-01-13 2006-01-12 ピラゾロ[3,4−d]ピリミジンエーテルを調製するための方法

Country Status (22)

Country Link
US (1) US7425630B2 (enExample)
EP (1) EP1838713A2 (enExample)
JP (1) JP2008526975A (enExample)
KR (1) KR20070114126A (enExample)
CN (1) CN101142216A (enExample)
AR (1) AR052557A1 (enExample)
AU (1) AU2006204940A1 (enExample)
BR (1) BRPI0606115A2 (enExample)
CA (1) CA2593345A1 (enExample)
CR (1) CR9224A (enExample)
DO (1) DOP2006000009A (enExample)
EA (1) EA013968B1 (enExample)
GT (1) GT200600011A (enExample)
HN (1) HN2006001493A (enExample)
IL (1) IL184365A0 (enExample)
MX (1) MX2007008381A (enExample)
NO (1) NO20074052L (enExample)
PA (1) PA8659701A1 (enExample)
PE (1) PE20061118A1 (enExample)
TW (1) TW200637865A (enExample)
WO (1) WO2006076455A2 (enExample)
ZA (1) ZA200705279B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10238722A1 (de) 2002-08-23 2004-03-11 Bayer Ag Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
HRP20050696B1 (en) 2003-01-14 2008-10-31 Arena Pharmaceuticals Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US7132426B2 (en) * 2003-07-14 2006-11-07 Arena Pharmaceuticals, Inc. Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7923465B2 (en) * 2005-06-02 2011-04-12 Glenmark Pharmaceuticals S.A. Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
PE20091211A1 (es) 2007-11-30 2009-09-14 Boehringer Ingelheim Int Derivados de pirazolopirimidina como moduladores de pde9a
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
WO2010009195A1 (en) * 2008-07-16 2010-01-21 Schering Corporation Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
CA2736304A1 (en) 2008-09-08 2010-03-11 Boehringer Ingelheim International Gmbh Pyrazolopyrimidines and their use for the treatment of cns disorders
GEP20146098B (en) 2009-03-31 2014-05-27 Boehringer Ingelheim Int 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their usage as pde9a modulators
US20100285145A1 (en) * 2009-05-08 2010-11-11 Pfizer Inc Gpr 119 modulators
JP2012528847A (ja) * 2009-06-05 2012-11-15 ファイザー・インク Gpr119調節因子としてのl−(ピペリジン−4−イル)−ピラゾール誘導体
SG182610A1 (en) 2010-01-27 2012-08-30 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
MX344770B (es) 2010-08-12 2017-01-06 Boehringer Ingelheim Int Gmbh * Derivados de 6-cicloalquil-1,5-dihidro-pirazolo (3,4-d) pirimidin-4-onas y su uso como inhibidores de pde9a.
MX2013003184A (es) 2010-09-22 2013-06-07 Arena Pharm Inc Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo.
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
AU2012267556B9 (en) 2011-06-09 2017-05-11 Rhizen Pharmaceuticals Sa Novel compounds as modulators of GPR-119
JP6567276B2 (ja) * 2014-05-13 2019-08-28 ソニーセミコンダクタソリューションズ株式会社 固体撮像素子、および電子機器
HK1243936A1 (zh) * 2014-12-06 2018-07-27 Intra-Cellular Therapies, Inc. 有机化合物
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
BR112017027656B1 (pt) 2015-06-22 2023-12-05 Arena Pharmaceuticals, Inc. Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
CA3053418A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
JP2019122134A (ja) 2018-01-04 2019-07-22 Ntn株式会社 スイッチング電源の力率改善用pwm制御装置
BR112020024762A2 (pt) 2018-06-06 2021-03-23 Arena Pharmaceuticals, Inc. métodos de tratamento de condições relacionadas ao receptor s1p1
IL308071A (en) * 2021-06-23 2023-12-01 Hoffmann La Roche Process for preparing NLRP3 inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050671B1 (en) 1980-04-28 1985-03-20 Teijin Limited Thiazolo(3,2-a)pyrimidine derivatives, process for preparing same, and drug containing same
EP0053678A1 (de) * 1980-12-05 1982-06-16 BASF Aktiengesellschaft 5-Amino-1-phenyl-4-cyanpyrazole, diese enthaltende herbizide Mittel, Verfahren zu ihrer Herstellung und ihre Anwendung als Herbizide
US4612376A (en) 1983-03-25 1986-09-16 Fujisawa Pharmaceutical Co., Ltd. Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
GB9114760D0 (en) 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
JP4022271B2 (ja) * 1995-10-31 2007-12-12 富士フイルム株式会社 ピラゾリルアゾフエノール色素
US6921763B2 (en) * 1999-09-17 2005-07-26 Abbott Laboratories Pyrazolopyrimidines as therapeutic agents
PT1212327E (pt) * 1999-09-17 2004-01-30 Abbott Gmbh & Co Kg Pirazolopirimidinas como agentes terapeuticos
DE10219435A1 (de) * 2002-05-02 2003-11-13 Bayer Cropscience Ag Substituierte Pyrazolo-pyrimidin-4-one
AU2003261204A1 (en) * 2002-07-23 2004-02-09 Smithkline Beecham Corporation Pyrazolopyrimidines as kinase inhibitors
US7132426B2 (en) * 2003-07-14 2006-11-07 Arena Pharmaceuticals, Inc. Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
GB0425035D0 (en) * 2004-11-12 2004-12-15 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2008526975A5 (enExample)
KR100888408B1 (ko) 아미노피리미딘 화합물의 제조 방법
JP2008526881A5 (enExample)
US20040230058A1 (en) Processes for the facile synthesis of diaryl amines and analogues thereof
CN101080391B (zh) 2-吡啶基乙基羧酰胺衍生物的制备方法
CN1140512C (zh) 制备4,6-二氯嘧啶的方法
CN105246878B (zh) 制备4,6‑双(芳氧基)嘧啶衍生物的方法
JP6050358B2 (ja) ベンゾオキサジノンをアミンと反応させることによるテトラゾール置換アントラニル酸ジアミド誘導体の製造方法
JP2017504576A5 (enExample)
RU2007125710A (ru) Способ получения n-фенилпиразол-1-карбоксамидов
JP4955658B2 (ja) ピリミジン誘導体
DK2776392T3 (en) PROCESS FOR THE PREPARATION OF 1-acyl-4-PHENYLSULFONYLPROLINAMID DERIVATIVES AND NEW INTERMEDIATE
JP2005536484A (ja) 光学活性(r)−アリールオキシプロピオン酸エステル誘導体の製造方法
MX2007013424A (es) Metodo para la preparacion de acidos 1,6-dihidro-6-oxo-4- pirimidinacarboxilicos opcionalmente 2-substituidos.
CA2320217A1 (en) N-(phenylsulfonyl) picolinamide derivatives, process for producing the same, and herbicide
RU94031212A (ru) Производные тетразолуксусной кислоты, фармацевтическая композиция на их основе
GB2276379A (en) Herbicidal compounds having a pentafluorosulphanyl group
CA2153839C (en) 2-(unsubstituted or substituted) (benzyloxy or phenoxy)-4-substituted-6-(meta-substituted phenoxy)pyridine, process for producing the same, and herbicidal composition
JPH05294944A (ja) 置換フタリド類および複素環フタリド類
WO1999052881A1 (en) 2-anilinopyrimidinone derivatives, intermediates in the production thereof, process for producing the same and pesticides containing the same as the active ingredient
DE69511035T2 (de) Verfahren zur Herstellung einer substituierten Benzol-Verbindung
JP2003327580A (ja) 2−(置換ベンゾイル)チアジン誘導体、その製造方法及び除草剤
RU2007148968A (ru) Способ получения 4-(1,6-дигидро-6-оксо-2-пиримидинил)амино-бензонитрила
CN1826332A (zh) 制备3-卤代-4,5-二氢-1h-吡唑的方法
JPH0566959B2 (enExample)